InvestorsHub Logo
Followers 71
Posts 7713
Boards Moderated 0
Alias Born 09/28/2012

Re: None

Saturday, 05/09/2020 1:54:23 PM

Saturday, May 09, 2020 1:54:23 PM

Post# of 232912
NP reputation is what’s giving the short positions ammunition right now. Can’t erase history.

Bruce Patterson is the one who is directly responsible for the proper development of leronlimab.

Main reason this hasn’t been accepted by the public is that NP is Ceo. IMO. I’d like to hear from the BOD member they just hired, if he quits then you know NP is being difficult. Looking at history it looks like he wouldn’t be the first.

The science is deafening, leronlimab works Andy they know it. The issue is the threat to Gilead and NP unwillingness to play ball.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News